Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Search results (475)

« Back to Publications

Cerebrospinal fluid proteome alterations related to depressive symptoms in cognitive decline and Alzheimer's disease.

Rabl M. et al, (2025), Alzheimers Dement, 21

Cerebrospinal fluid proteomic profiling of individuals with mild cognitive impairment and suspected non-Alzheimer's disease pathophysiology.

Delvenne A. et al, (2023), Alzheimers Dement, 19, 807 - 820

Identification of a possible proteomic biomarker in Parkinson's disease: discovery and replication in blood, brain and cerebrospinal fluid.

Winchester L. et al, (2023), Brain Commun, 5

Blood-based multivariate methylation risk score for cognitive impairment and dementia

Koetsier J. et al, (2023)

Glycosylated clusterin species facilitate Aβ toxicity in human neurons.

Foster EM. et al, (2022), Sci Rep, 12

New insights into the genetic etiology of Alzheimer's disease and related dementias.

Bellenguez C. et al, (2022), Nat Genet, 54, 412 - 436

Neurons derived from individual early Alzheimer's disease patients reflect their clinical vulnerability.

Ng B. et al, (2022), Brain Commun, 4

Multivariate GWAS of Alzheimer’s disease CSF biomarker profiles implies GRIN2D in synaptic functioning

Neumann A. et al, (2022)

Characterization ofAPOEChristchurch carriers in 455,306 UK Biobank participants

He K. et al, (2022)

Identification of a novel proteomic Biomarker in Parkinson’s Disease: Discovery and Replication in Blood, brain and CSF

Winchester L. et al, (2021)

Serum from Older Adults Increases Apoptosis and Molecular Aging Markers in Human Hippocampal Progenitor Cells.

de Lucia C. et al, (2021), Aging Dis, 12, 2151 - 2172

Genome and epigenome wide studies of plasma protein biomarkers for Alzheimer’s disease implicate TBCA and TREM2 in disease risk

Hillary RF. et al, (2021)

Comorbidity between Alzheimer's disease and major depression: a behavioural and transcriptomic characterization study in mice.

Martín-Sánchez A. et al, (2021), Alzheimers Res Ther, 13

ANMerge: A Comprehensive and Accessible Alzheimer's Disease Patient-Level Dataset.

Birkenbihl C. et al, (2021), J Alzheimers Dis, 79, 423 - 431

Rare variants in IFFO1, DTNB and NLRC3 associate with Alzheimer’s disease CSF profile of neuronal injury and inflammation

Neumann A. et al, (2021)

Load More

1
2
3
4
5
6
7
...
»